Back to Market返回行情

ENOV Enovis Corporation

USHealthcare
$25.75+2.10%ClosedMarket Cap: $1.48B

As of 2026-07-10 16:00

Why ENOV matters now

Enovis Corporation (ENOV) is a US stock in Healthcare. The latest InvestLog snapshot shows $25.75 with +2.10% on the session and $1.48B in market capitalization; recent performance reads 1-month -14.71% and YTD -17.53%.

The latest financial table shown here is Q1 2026, with revenue of $589.2M, net income of $-8.8M, and EPS of $-0.15. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.8%.

The latest indexable market news headline is "4 Top Growth Stocks Worth Buying Under $100 Today" from Fool - Investing News.

Additional event context on this page matters because analyst consensus is Buy with a median target of $45.50; recent insider activity includes Engert Oliver filing P-Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

0.84

P/S

0.56

EV/EBITDA

-3.53

DCF Value

$-117.46

FCF Yield

2.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

56.8%

Operating Margin

2.7%

Net Margin

-49.9%

ROE

-60.1%

ROA

-29.7%

ROIC

1.9%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$589.2M$-8.8M$-0.15
Q4 2025$575.8M$-520.6M$-9.17
FY 2025$2.25B$-1.18B$-20.86
Q3 2025$548.9M$-571.1M$-10.06

Analyst Ratings

Consensus

Buy

Target (Consensus)

$44.75

Target (Median)

$45.50

Target Range

$36.00 - $52.00

Strong Buy: 2Buy: 9Hold: 1Sell: 0Strong Sell: 0
BTIGBuy
2026-05-22
Evercore ISI GroupOutperform
2026-05-08
Wells FargoOverweight
2026-05-08
Evercore ISI GroupOutperform
2026-04-06
BTIGBuy
2026-02-26

Trading Activity

Insider Trades

Engert Oliverofficer: Chief Administrative Officer
Buy2026-06-16
Engert Oliverofficer: Chief Administrative Officer
Sell2026-06-16
Engert Oliverofficer: Chief Administrative Officer
Buy2026-06-15
Engert Oliverofficer: Chief Administrative Officer
Buy2026-06-15
Engert Oliverofficer: Chief Administrative Officer
Buy2026-06-11

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.49

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.